Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Corner Health Announces $32.5 Million in Seed and Series A Financing to Help Independent Clinicians Rebuild Primary Care
Corner Health, a company designed to rebuild the healthcare system by empowering Nurse Practitioners (NPs) to start and scale their own local primary care practices, announced today it has raised $32.5 million in Seed and Series A financing. Their recent Series A was led by Oak HC/FT, with participation from existing investors First Round Capital and Zigg Capital. The investment follows a period of rapid growth for Corner Health, which has established a network of more than 70 provider-owned primary care practices. Corner Health is the fastest-growing primary care network in Arizona and Washington and has enabled 35,000+ patient visits in the past year.
The funding comes at a pivotal moment for healthcare. Despite unprecedented investment in AI, more than 100 million Americans still lack access to a primary care provider, clinicians are burning out at record rates, and patient visits continue to get shorter. Corner Health is taking the opposite approach: using AI to create more time for the provider-patient relationship, not less.
“I grew up watching my mom run her own private practice, and I saw firsthand how powerful it is when a clinician owns the relationship with their patient,” said Lava Sunder, Co-Founder and CEO at Corner Health. “The tragedy is that the economics of healthcare have made that model increasingly difficult to sustain. Healthcare has spent decades pushing clinicians into larger and larger systems, often at the expense of time with patients. Via Corner Health’s network, the most common word that appears in patient reviews is ‘listen.’ When providers have more time, patients feel heard.”
The backbone of Corner Health’s model is Cora, an AI-native practice operating system designed to automate the full spectrum of brick-and-mortar primary care operations, including scheduling, patient communication, billing, lab orders, referrals, and prior authorizations. Built for scale and in-person clinical environments, Cora enables 90% of Corner Health clinics to operate with no additional staff, dramatically reducing overhead and giving NPs more time to focus on patient care.
“The dominant use of AI in healthcare today is helping clinicians move faster and see more patients,” said Anne Gifford, Co-Founder and COO of Corner Health…
Full release here, originally announced July 13th, 2026.
TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement Platform
Company Repositions as an AI-First Clinical Enablement Platform, Bringing FDA-Cleared AI-Powered Insights into Virtual Primary Care to Support Cardiopulmonary and Oncology Care
TytoCare, pioneer of remote physical examination technology featuring FDA-cleared medical devices, today announced two major developments: the appointment of Adam Pellegrini as Chief Executive Officer, and the closing of a $25 million-plus growth round led by Insight Partners along with HOOP, OliveTree, OrbiMed, Qumra Capital, Qualcomm Ventures, and others. The company is expanding its platform to deliver clinical-grade remote care for patients with chronic and complex disease, positioning TytoCare to redefine how virtual primary care is delivered across high-acuity chronic disease populations.
Pellegrini brings more than two decades of experience at the intersection of digital health, consumer health technology, and large-scale clinical programs. His appointment comes as TytoCare moves to embed its remote examination platform and FDA-cleared AI-powered SaMD (software as a medical device) algorithms directly into integrated care pathways for remote cardiopulmonary monitoring, oncology support, and complex chronic disease management, disease areas where the gap between in-person clinical rigor and virtual care delivery has remained wide.
TytoCare’s platform combines a handheld examination platform featuring FDA-cleared medical devices — capable of capturing clinical-grade heart, lung, ear, skin, throat, and abdomen data — with a suite of FDA-cleared AI-powered SaMD algorithms that enable clinicians to conduct comprehensive remote physical exams with diagnostic confidence previously achievable only in person. The company’s expanded clinical enablement strategy is set to deepen integrations with leading health systems, payers, and employer health programs, with particular focus on congestive heart failure (CHF), COPD, post-surgical recovery, and oncology treatment monitoring.
“The convergence of a clinically validated exam device, AI-powered diagnostic algorithms, and the urgent demand from health systems for real clinical intelligence at the point of virtual care is an extraordinary and rare combination,” said Adam Pellegrini, Chief Executive Officer. “TytoCare has built the foundational infrastructure for the next generation of intelligent remote care, and I could not be more energized to lead this next chapter.”
The oversubscribed financing round, led by Insight Partners with participation from existing strategic investors, reflects institutional conviction in TytoCare’s market position and the accelerating commercial demand for AI-enabled remote diagnostics…
Full release here, originally announced July 15th, 2026.
No comments:
Post a Comment